DAVID S FOLLOWILL to United States
This is a "connection" page, showing publications DAVID S FOLLOWILL has written about United States.
Connection Strength
0.173
-
Results From the Imaging and Radiation Oncology Core Houston's Anthropomorphic Phantoms Used for Proton Therapy Clinical Trial Credentialing. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):242-248.
Score: 0.039
-
Independent dose per monitor unit review of eight U.S.A. proton treatment facilities. Med Phys. 2014 Jan; 41(1):012103.
Score: 0.033
-
Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the collaborative ocular melanoma study: COMS report no. 21. Arch Ophthalmol. 2003 Aug; 121(8):1163-71.
Score: 0.016
-
The Value of On-Site Proton Audits. Int J Radiat Oncol Biol Phys. 2022 03 15; 112(4):1004-1011.
Score: 0.014
-
NRG Oncology medical physicists' manpower survey quantifying support demands for multi-institutional clinical trials. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):324-331.
Score: 0.011
-
Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases. Int J Radiat Oncol Biol Phys. 2017 01 01; 97(1):155-163.
Score: 0.010
-
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e291-e298.
Score: 0.010
-
Imaging and Data Acquisition in Clinical Trials for Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Feb 01; 94(2):404-11.
Score: 0.009
-
A six-year review of more than 13,000 patient-specific IMRT QA results from 13 different treatment sites. J Appl Clin Med Phys. 2014 Sep 08; 15(5):4935.
Score: 0.009
-
Reproducibility in patient-specific IMRT QA. J Appl Clin Med Phys. 2014 May 08; 15(3):4741.
Score: 0.009
-
Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010 Aug; 37(8):4078-101.
Score: 0.007
-
Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials. Int J Radiat Oncol Biol Phys. 2008; 71(1 Suppl):S71-5.
Score: 0.006